As shown in Fig. 3A, the percentage of non-classic monocytes (CD14+CD16++) in PBMCs was significantly increased in women with SLE compared to healthy women (median [IQR], 20.79% [14.32%–27.26%] and 31.06% [20.67%–57.59%] for controls and patients respectively). This evidence concerns the gene CD14 and systemic lupus erythematosus.